Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-EGFRvIII antibodies and uses thereof

Anti-EGFRvIII antibodies and uses thereof

US Patent 10738124 · Granted Aug 11, 2020

Estimated economic value: $88,995,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MSR1 antibodies and methods of use thereof2025
Non-human animals expressing humanized CD3 complex2025
Diels-Alder conjugation methods2025
Mouse having a humanized cluster of differentiation 47 gene2025
Biologically active molecules, conjugates thereof, and therapeutic uses2025
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD2025
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD2025
Maytansinoid derivatives, conjugates thereof, and methods of use2025
Multispecific antigen-binding molecules and uses thereof2025
Multispecific antigen-binding molecules and uses thereof2025
Multispecific antigen-binding molecules and uses thereof2025
Anti-PCSK9 antibodies2025